PHARMACEUTICAL COMPOSITION CONTAINING CRYSTAL OF THIAZOLIDINEDIONE COMPOUND

PROBLEM TO BE SOLVED: To provide a pharmaceutical composition containing the crystals of a thiazolidinedione compound as an active ingredient, and useful as a technical product for producing peroxisome proliferation factor-activating receptor (PPAR)γ activating agents, anticancer pharmaceutical comp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	NIHEI SATORU, KAJINO HISAYOSHI, NUMAGAMI EIJI
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To provide a pharmaceutical composition containing the crystals of a thiazolidinedione compound as an active ingredient, and useful as a technical product for producing peroxisome proliferation factor-activating receptor (PPAR)γ activating agents, anticancer pharmaceutical compositions. SOLUTION: There is provided the pharmaceutical composition containing the hydrate crystals of 5-(4-ä[6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1-H-benzimidazol-2-yl]methoxy}benzyl)-1,3-thiazolidine-2,4-dione represented by formula (I) as an active ingredient. COPYRIGHT: (C)2011,JPO&INPIT